The first cancer vaccine — cervical cancer vaccine

Human first cancer vaccine — cervical cancer vaccine

United States food and Drug Administration (FDA) an Advisory Board block adopted allowed Merck Sharp and Dohme company (Merck) cervical cancer vaccine listing recommendations. This means that human cancer war is about to enter a new phase of the landmark.

It is expected that in the next 8 days before the FDA will decide whether to approve the Merck Sharp and Dohme cervical cancer vaccine guardian Cyr. Typically, the FDA will adopt the recommendations of the Advisory Board.

China Academy of tumor by Joe youlin Professor evaluation said that with the advent of the vaccine, "cervical cancer becomes human in a variety of methods to comprehensive prevention and eradication of the first cancer. ”

Incredible 100%

In recent years scientists have clear, almost all of the cervix by the human papilloma virus (HPV). Of these, more than 2/3 of cervical cancer cases can be attributed to two types of HPV: 16-18.

"In a variety of cancers, the cause of most clearly is cervical cancer. "China's Cancer Research Foundation Vice President Dong Zhiwei Professor says. After figuring out the cause, vaccine research is possible.

To date, Merck Sharp and Dohme has 33 countries around the world recruit 2.7 000 women and men to participate in clinical trials. The results showed that the vaccine in preventing HPV16 and HPV18 induced cervical and vaginal and vulvar Dysplasia of efficient reach 100%!

Prior to this, it's never what vaccines or drugs to achieve 100% efficient. This results enable researchers overjoyed, although they are also unable to clearly explain why. Guardian Cyr's patent inventor, Merck Sharp and Dohme medicines research and Development Department, Deputy Director of the history of the force, said: "we had anticipated this vaccine can play a role, but I didn't think there would be so perfect. ”

Another pharmaceutical giant GlaxoSmithKline (GSK) vaccine HPV in research and development, in March this year, submitted to the European market and plan to submit to the FDA at the end of this year listing. In April this year, the journal the Lancet published clinical findings, GlaxoSmithKline vaccine similarly to 100 per cent against the HPV16 and HPV18 associated precancerous lesions.

"Cervical cancer vaccine clinical research results is too good, so many (national or regional drug management) agencies in accelerated approval. "The Chinese Academy of medical oncology Professor Joe youlin.

Foreign media that cervical cancer vaccine will become the world's first cancer vaccine. But many experts expressed a different view.

"If it is the first cancer vaccine, hepatitis b vaccine?" comes from the United States for the promotion of appropriate technology in health (PATH) of game ideas (John Sellors), said, "hepatitis b is caused by liver cancer is one of the important factors, many of the countries to the new-born infant injection of hepatitis b vaccine, the first anti-HBV, also to prevent their future risk of liver cancer. ”

However, experts tend to feel that cervical cancer vaccine is the first designed directly against cancer vaccines.